Cite
HARVARD Citation
Weihrauch, M. et al. (n.d.). Phase I clinical study of the toll-like receptor 9 agonist MGN1703 in patients with metastatic solid tumours. European journal of cancer. 51 (2), pp. 146-156. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Weihrauch, M. et al. (n.d.). Phase I clinical study of the toll-like receptor 9 agonist MGN1703 in patients with metastatic solid tumours. European journal of cancer. 51 (2), pp. 146-156. [Online].